Decheng Capital »

Helix Acquisition Corp shares owned by Decheng Capital

Quarter-by-quarter ownership of Helix Acquisition Corp shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Helix Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp by Decheng Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.3M 167k 43.97
2024-03-31 $8.4M 167k 50.23

More positions owned by Decheng Capital

Cg Oncology (CGON)
Nuvation Bio (NUVB)
Arcus Biosciences Incorporated (RCUS)
Zentalis Pharmaceuticals (ZNTL)
Krystal Biotech (KRYS)
BeyondSpring SHS (BYSI)
Illumina (ILMN)
Merus N V (MRUS)
Phathom Pharmaceuticals (PHAT)
Newamsterdam Pharma Co Nv (NAMS)
Helix Acquisition Corp
4d Molecular Therapeutics In (FDMT)
Crinetics Pharmaceuticals In (CRNX)
Cytokinetics (CYTK)
Legend Biotech Corp- Adr (LEGN)

View all positions for Decheng Capital

Top funds holding Helix Acquisition Corp

Decheng Capital

View all funds holding Helix Acquisition Corp